Chemours (CC) Current Deferred Revenue (2015 - 2021)

Chemours has reported Current Deferred Revenue for 7 years, with the latest figure at $3.0 million in Q4 2021.

• On a quarterly basis, Current Deferred Revenue fell 57.14% year-over-year to $3.0 million in Q4 2021; TTM through Dec 2021 was $3.0 million, a 57.14% decrease from a year earlier, with the FY2021 full-year figure at $3.0 million, down 57.14% from the prior year.
• Current Deferred Revenue was $3.0 million for Q4 2021 at Chemours, up from $2.0 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $23.0 million in Q1 2017, with the low at $2.0 million in Q3 2021.
• Average Current Deferred Revenue over 5 years is $7.3 million, with a median of $7.0 million recorded in 2019.
• The sharpest annual moves came in 2017 and 2019: Current Deferred Revenue sank 89.47% in 2017, then soared 60.0% in 2019.
• Over 5 years, Current Deferred Revenue stood at $8.0 million in 2017, then slipped by 25.0% to $6.0 million in 2018, then advanced by 16.67% to $7.0 million in 2019, then changed by 0.0% to $7.0 million in 2020, then sank by 57.14% to $3.0 million in 2021.
• The last three Current Deferred Revenue figures came in at $3.0 million (Q4 2021), $2.0 million (Q3 2021), and $3.0 million (Q2 2021), per Business Quant data.